As of 2025-07-11, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is (32.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.48 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is -437.9%.
The range of the Relative Valuation is (31.89) - (44.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 18.9x | 13.4x |
| Forward P/E multiples | 13.6x - 21.6x | 14.0x |
| Fair Price | (31.89) - (44.23) | (32.03) |
| Upside | -436.4% - -566.6% | -437.9% |
| Date | P/E |
| 2025-07-09 | -3.95 |
| 2025-07-08 | -3.96 |
| 2025-07-07 | -3.67 |
| 2025-07-03 | -3.62 |
| 2025-07-02 | -3.53 |
| 2025-07-01 | -3.34 |
| 2025-06-30 | -3.30 |
| 2025-06-27 | -3.40 |
| 2025-06-26 | -3.40 |
| 2025-06-25 | -3.43 |
| 2025-06-24 | -3.45 |
| 2025-06-23 | -3.37 |
| 2025-06-20 | -3.40 |
| 2025-06-18 | -3.43 |
| 2025-06-17 | -3.34 |
| 2025-06-16 | -3.67 |
| 2025-06-13 | -3.77 |
| 2025-06-12 | -3.73 |
| 2025-06-11 | -3.81 |
| 2025-06-10 | -3.90 |
| 2025-06-09 | -3.96 |
| 2025-06-06 | -3.95 |
| 2025-06-05 | -3.60 |
| 2025-06-04 | -3.56 |
| 2025-06-03 | -3.59 |
| 2025-06-02 | -3.42 |
| 2025-05-30 | -3.34 |
| 2025-05-29 | -3.34 |
| 2025-05-28 | -3.33 |
| 2025-05-27 | -3.20 |
| 2025-05-23 | -3.05 |
| 2025-05-22 | -3.04 |
| 2025-05-21 | -2.95 |
| 2025-05-20 | -2.99 |
| 2025-05-19 | -2.88 |
| 2025-05-16 | -2.93 |
| 2025-05-15 | -3.25 |
| 2025-05-14 | -2.83 |
| 2025-05-13 | -2.86 |
| 2025-05-12 | -2.77 |
| 2025-05-09 | -3.11 |
| 2025-05-08 | -3.17 |
| 2025-05-07 | -3.11 |
| 2025-05-06 | -3.28 |
| 2025-05-05 | -3.10 |
| 2025-05-02 | -3.34 |
| 2025-05-01 | -3.23 |
| 2025-04-30 | -3.42 |
| 2025-04-29 | -3.21 |
| 2025-04-28 | -3.17 |